Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics, genomic features, and recurrence risk of early-stage MET exon 14 mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Recondo, G.; Guo, R.; Cravero, P.; Ricciuti, B.; Falcon, C.; Vokes, N.; Kris, M. G.; Leonardi, G. C.; Lamberti, G.; Nguyen, T.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • High-dose osimertinib for CNS progression in EGFR+ non-small cell lung cancer (NSCLC): A multi-institutional experience
    Meeting Abstract

    Piper-Vallillo, A.; Rotow, J. K.; Aredo, J. V.; Shaverdashvili, K.; Luo, J.; Carlisle, J. W.; Husain, H.; Muzikansky, A.; Heist, R. S.; Rangachari, D.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1
    Meeting Abstract

    Ramalingam, S. S.; Ciuleanu, T. E.; Pluzanski, A.; Lee, J. S.; Schenker, M.; Caro, R. B.; Lee, K. H.; Zurawski, B.; Audigier-Valette, C.; Provencio, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase II study of TAK228 in patients with advanced non-small cell lung cancer (NSCLC) harboring NFE2L2 and KEAP1 mutations
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Plodkowski, A. J.; Fan, P. D.; Rudin, C. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Tepotinib in patients (pts) with NSCLC with MET exon 14 (METex14) skipping: Health-related quality of life (HRQoL)
    Meeting Abstract

    Paik, P. K.; Horn, L.; Kowalski, D. M.; Patel, J. D.; Griesinger, F.; Han, J. Y.; Smit, E. F.; Kato, T.; Le, X.; Scheele, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Peritoneal mesotheliomas characterized by less cell-cycle alterations and more TRAF7 alterations than malignant pleural mesotheliomas
    Meeting Abstract

    Offin, M.; Egger, J. V.; Cercek, A.; Nash, G. M.; Ladanyi, M.; Zauderer, M. G.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • CT and PET radiomic features associated with major pathologic response to neoadjuvant immunotherapy in early-stage non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Nakajima, E. C.; Leal, J. P.; Fu, W.; Wang, H.; Chaft, J. E.; Hellmann, M. D.; Pomper, M.; Forde, P. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Hui, A. B.; Chabon, J. J.; Moding, E. J.; Lebow, E. S.; Araujo, J. A.; Isbell, J. M.; Jones, D. R.; Ginsberg, M. S.; Myers, M. L.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Luo, J.; Bandlamudi, C.; Ricciuti, B.; Vokes, N.; Schoenfeld, A. J.; Egger, J. V.; Sauter, J. L.; Plodkowski, A. J.; Preeshagul, I. R.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial
    Meeting Abstract

    Li, B. T.; Li, T.; Johnson, M. L.; Waqar, S. N.; Zhu, V. W.; Ou, S. H. I.; Lin, J. J.; Wang, D.; Shapiro, G.; Wang, J. S. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save